DC Funds, LP — Q2 2023 13F-HR

← DC Funds, LP

Q2 2023 · 13F-HR

DC Funds, LPholdings as filed

Filed 2023-08-10 · accession 0001398344-23-014529

$4.7M

Reported value

Positions

2023-06-30

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
95075A107	HOWL	WEREWOLF THERAPEUTICS INC	$1.8M	38.3%	589,102	Common	SOLE
89854M101	TCRX	TSCAN THERAPEUTICS INC	$1.6M	33.5%	630,000	Common	SOLE
91864C107	BRNS	VACCITECH PLC	$1.3M	28.2%	642,204	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.